Emergent BioSolutions Awarded $62.4 Million Contract Modification for BAT® Antitoxin by U.S. Department of Health and Human Services
23/6 14:13
Emergent BioSolutions receives a $62.4 million contract modification to supply Botulism Antitoxin for U.S. public health protection....